|
|
|
07173
|
|
|
P.I.:
|
Jeffrey Wong, MD
|
(Institutional)
|
|
Title:
|
Correlating Organ Dose and Dose-Volume with Toxicities After Total Marrow Irradiation (TMI) Using Helical Tomotherapy in Patients with Multiple Myeloma Undergoing Hematopoetic Cell Transplantation (HCT)
|
|
|
07152
|
|
|
P.I.:
|
Jeffrey Wong, MD
|
(NCI Approved External Peer Review)
|
|
Title:
|
A Phase I Trial of External Beam Radiotherapy, Combined with Cisplatin and Etoposide OR Carboplatin and Paclitaxel, Followed by Consolidation Radioimmunotherapy (Y-90-Mx-DTPA-cT84.66), in Unresectable OR Medically Inoperable, Non-metastatic CEA-producing Stage III or IIB Non-Small Cell Lung Cancer
|
| | |
|
|
04122
|
|
|
P.I.:
|
Jeffrey Wong, MD
|
(NCI Approved External Peer Review)
|
|
Title:
|
A Phase I/II Trial of Radioimmunotherapy (Y90 cT8.66), Gemcitabine and Hepatic Arterial Infusion of Fudr for Metastatic Colorectal Carcinoma to the Liver
|
| | |
|
|
04085
|
|
|
P.I.:
|
Jeffrey Wong, MD
|
(NCI Approved External Peer Review)
|
|
Title:
|
Detection of Carcinomas Using 123Iodine-Labeled T84.66 Diabody Antibody Fragment to Carcinoembryonic Antigen (CEA)
|
| | |
|